ST中珠(600568.SH):中珠富盈清算註銷完成
格隆匯1月21日丨ST中珠(600568.SH)公佈,中珠醫療於2021年10月27日召開第九屆董事會第二十七次會議,審議通過《關於橫琴中珠富盈投資管理企業(有限合夥)擬清算的議案》。鑑於橫琴中珠富盈投資管理企業(有限合夥)(“中珠富盈”)存續期已屆滿,全體合夥人一致提議不再延長存續期,並觸發清算條款。
截止本公吿披露日,中珠富盈已完成相關清算註銷程序,並取得了橫琴粵港澳深度合作區商事服務局於2022年1月20日出具的《核准註銷登記通知書》(粵橫琴核注通內字(2022)第44000312200001011號),核准中珠富盈註銷登記,收繳企業《營業執照》正副本,中珠富盈清算註銷工作完成。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.